Cited by 1,947Receptor Mechanisms and SignalingIon channel regulation and functionNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 3 of the 7 references it cites were found in a registry or an index, and 4 are not checked yet.

Guide to Receptors and Channels (GRAC), 5th edition

Open access

Alexander, SPH, Mathie, A, Peters, JA·2011·British Journal of Pharmacology

DOI 10.1111/j.1476-5381.2011.01649_1.xPMC PMC3315626

Open this paper in CoChat — free account Open PDF

Abstract

The Fifth Edition of the 'Guide to Receptors and Channels' is a compilation of the major pharmacological targets divided into seven sections: G protein-coupled receptors, ligand-gated ion channels, ion channels, catalytic receptors, nuclear receptors, transporters and enzymes. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside suggestions for further reading. Available alongside this publication is a portal at http://www.GuideToPharmacology.org which is produced in close association with NC-IUPHAR and allows free online access to the information presented in the Fifth Edition.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2011.01649_1.x

Cites

3 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects
Kanai, Y., & Hediger, M. A. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1146-4 · Cited by 450
The thermo‐TRP ion channel family: properties and therapeutic implications
Vay, L., Gu, C., & McNaughton, P. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01601.x · Cited by 313
Guide to Receptors and Channels (GRAC), 4th edition
Alexander, S. P. H., & Peters, J. A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00499.x · Cited by 249
Self-citation
The oligomeric state sets GABAB receptor signalling efficacy
Comps‐Agrar, L., Kniazeff, J., Nørskov-Lauritsen, L., Maurel, D., Gassmann, M., Gregor, N., Prézeau, L., Bettler, B., Durroux, T., Trinquet, E., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.143 · Cited by 103
Design and synthesis of the CB1 selective cannabinoid antagonist AM281: A potential human SPECT ligand
Lan, R., Lu, Q., Fan, P., Gatley, J. S., Volkow, N. D., Fernando, S. R., Pertwee, R. G., & Makriyannis, A. (1999) · AAPS PharmSci · doi:10.1208/ps010204 · Cited by 98
X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes.
Vanhoutte, P. M., Humphrey, P. P. A., & Spedding, M. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06936-4 · Cited by 78
The VPAC 2 agonist peptide histidine isoleucine (PHI) up‐regulates glutamate transport in the corpus callosum of a rat model of amyotrophic lateral sclerosis (hSOD1 G93A ) by inhibiting caspase‐3 mediated inactivation of GLT‐1a
Goursaud, S., Focant, M. C., Berger, J. V., Nizet, Y., Maloteaux, J., & Hermans, E. (2011) · The FASEB Journal · doi:10.1096/fj.11-182337 · Cited by 14

Show all 2 references

Sorted by citations

Items 301–400 of 1,000

Transient receptor potential melastatin 4 inhibitor 9‐phenanthrol abolishes arrhythmias induced by hypoxia and re‐oxygenation in mouse ventricle
Simard, C., Sallé, L., Rouet, R., & Guinamard, R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01715.x · Cited by 93
A novel antagonist of the prostaglandin E2 EP4 receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models
Chen, Q., Muramoto, K., Masaaki, N., Ding, Y., Yang, H., Mackey, M., Li, W., Inoue, Y., Ackermann, K. E., Shirota, H., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00647.x · Cited by 93
Transport of interleukin‐1 across cerebromicrovascular endothelial cells
Skinner, R., Gibson, R. M., Rothwell, N. J., Pinteaux, E., & Penny, J. C. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00129.x · Cited by 93
1,3,5-Triazine-based analogues of purine: From isosteres to privileged scaffolds in medicinal chemistry
Lim, F. P. L., & Dolzhenko, A. V. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.112 · Cited by 96
CGRP in the trigeminovascular system: a role for CGRP , adrenomedullin and amylin receptors?
Walker, C. S., & Hay, D. L. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12129 · Cited by 93
Systemic bile acid sensing by G protein‐coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP‐1 release
Ullmer, C., Alvarez Sanchez, R., Sprecher, U., Raab, S., Mattei, P., Dehmlow, H., Sewing, S., Iglesias, A., Beauchamp, J., & Conde‐Knape, K. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12158 · Cited by 92
Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX2receptor
Malherbe, P., Borroni, E., Gobbi, L. B., Knust, H., Nettekoven, M. H., Pinard, E., Roche, O., Rogers‐Evans, M., Wettstein, J. G., & Moreau, J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00127.x · Cited by 91
High concentrations of dexmedetomidine inhibit compound action potentials in frog sciatic nerves without α 2 adrenoceptor activation
Kosugi, T., Mizuta, K., Fujita, T., Nakashima, M., & Kumamoto, E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00833.x · Cited by 92
Emodin suppresses lipopolysaccharide‐induced pro‐inflammatory responses and NF‐κB activation by disrupting lipid rafts in CD14‐negative endothelial cells
Meng, G., Liu, Y., Lou, C.-C., & Yang, H. S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00993.x · Cited by 92
The role of the membrane potential in chondrocyte volume regulation
Lewis, R., Asplin, K. E., Bruce, G., Dart, C., Mobasheri, A., & Barrett‐Jolley, R. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22646 · Cited by 92
Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and ‘cannabinoid‐like’ receptors in small arteries
Daly, C. S. M., Ross, R., Whyte, J., Henstridge, C. M., Irving, A. J., & McGrath, J. C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00608.x · Cited by 93
The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear‐conditioned analgesia and controls fear expression in the presence of nociceptive tone
Olango, W., Roche, M., Ford, G., Harhen, B., & Finn, D. P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01478.x · Cited by 93
Participation of CYP2C8 and CYP3A4 in the N‐demethylation of imatinib in human hepatic microsomes
Nebot, N., Crettol, S., D’Esposito, F., Tattam, B. N., Hibbs, D. E., & Murray, M. T. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00946.x · Cited by 91
Cannabidiol improves brain and liver function in a fulminant hepatic failure‐induced model of hepatic encephalopathy in mice
Avraham, Y., Grigoriadis, N. K., Poutahidis, T., Vorobiev, L., Magen, I., Ilan, Y., Mechoulam, R., & Berry, E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01179.x · Cited by 93
CGRP function‐blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat
Zeller, J., Poulsen, K., Sutton, J. E., Abdiche, Y. N., Collier, S., Chopra, R., García, C., Pons, J., Rosenthal, A., & Shelton, D. L. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.334 · Cited by 95
Wnt1, FoxO3a, and NF-κB oversee microglial integrity and activation during oxidant stress
Shang, Y., Chong, Z. Z., Hou, J., & Maiese, K. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.04.009 · Cited by 91
Orexin A in rat rostral ventrolateral medulla is pressor, sympatho‐excitatory, increases barosensitivity and attenuates the somato‐sympathetic reflex
Shahid, I. Z., Rahman, A. A., & Pilowsky, P. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01694.x · Cited by 92
Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9‐tetrahydrocannabinol in BV‐2 microglial cells
Juknat, A., Pietr, M., Kozela, E., Rimmerman, N., Levy, R., Coppola, G., Geschwind, D. H., & Vogel, Z. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01461.x · Cited by 90
TRP channels in neurogastroenterology: opportunities for therapeutic intervention
Boesmans, W., Owsianik, G., Tack, J. F., Voets, T., & Berghe, P. V. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01009.x · Cited by 95
A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone‐based enzyme inhibitors
King, A., Lodola, A., Carmi, C., Fu, J., Mor, M., & Piomelli, D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00276.x · Cited by 91
Function and Pharmacology of Spinally-Projecting Sympathetic Pre-Autonomic Neurones in the Paraventricular Nucleus of the Hypothalamus
Barrett‐Jolley, R., Nunn, N., Womack, M. D., & Dart, C. (2011) · Current Neuropharmacology · doi:10.2174/157015911795596531 · Cited by 90
TNF-α induces CXCL1 chemokine expression and release in human vascular endothelial cells in vitro via two distinct signaling pathways
Lo, H., Lai, T., Li, C.-H., & Wu, W. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.182 · Cited by 92
β 2 -Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids
Holden, N. S., Bell, M. J., Rider, C. F., King, E. M., Gaunt, D. D., Leigh, R., Johnson, M. W., Siderovski, D. P., Heximer, S. P., Giembycz, M. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110226108 · Cited by 90
G‐Protein Oestrogen Receptor 1: Trials and Tribulations of a Membrane Oestrogen Receptor
Srivastava, D. P., & Evans, P. D. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12071 · Cited by 89
Pregnenolone sulfate: from steroid metabolite to TRP channel ligand
Harteneck, C. (2013) · Molecules · doi:10.3390/molecules181012012 · Cited by 89
Potent vasorelaxant activity of the TMEM16A inhibitor T16A inh ‐A01
Davis, A. J., Shi, J. R., Pritchard, H. A. T., Chadha, P. S., Leblanc, N., Vasilikostas, G., Yao, Z., Verkman, A., Albert, A. P., & Greenwood, I. A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02199.x · Cited by 89
The role of monoamines in the changes in body temperature induced by 3,4‐methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives
Docherty, J. R., & Green, A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00722.x · Cited by 89
Thyroid hormone potentiates insulin signaling and attenuates hyperglycemia and insulin resistance in a mouse model of type 2 diabetes
Lin, Y., & Sun, Z. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01056.x · Cited by 89
Inhibition of voltage‐gated Na + currents in sensory neurones by the sea anemone toxin APETx2
Blanchard, M. G., Rash, L. D., & Kellenberger, S. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01674.x · Cited by 89
α2‐Adrenoceptor action on cell proliferation and mammary tumour growth in mice
Bruzzone, A., Piñero, C. P., Castillo, L. F., Sarappa, M. G., Rojas, P. A., Lanari, C., & Lüthy, I. A. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.278 · Cited by 90
Cannabinoid CB 1 receptors transactivate multiple receptor tyrosine kinases and regulate serine/threonine kinases to activate ERK in neuronal cells
Dalton, G. D., & Howlett, A. C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01455.x · Cited by 89
Microcirculatory dysfunction and resuscitation: why, when, and how
Moore, J. P. R., Dyson, A., Singer, M., & Fraser, J. F. (2015) · British Journal of Anaesthesia · doi:10.1093/bja/aev163 · Cited by 93
Central activation of the cholinergic anti‐inflammatory pathway reduces surgical inflammation in experimental post‐operative ileus
The, F., Cailotto, C., van der Vliet, J., de Jonge, W. J., Bennink, R. J., Buijs, R. M., & Boeckxstaens, G. E. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01296.x · Cited by 89
Public Domain Databases for Medicinal Chemistry
Nicola, G., Liu, T., & Gilson, M. K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300501t · Cited by 89
Bitter Taste Receptors (TAS2Rs) in Human Lung Macrophages: Receptor Expression and Inhibitory Effects of TAS2R Agonists
Grassin‐Delyle, S., Salvator, H., Mantov, N., Abrial, C., Brollo, M., Faisy, C., Naline, E., Couderc, L., & Devillier, P. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01267 · Cited by 88
Agonists at GPR119 mediate secretion of GLP‐1 from mouse enteroendocrine cells through glucose‐independent pathways
Lan, H., Lin, H. V., Cf, W., Wright, M. J., Xu, S. S., Kang, L., Juhl, K., Hedrick, J., & Kowalski, T. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01754.x · Cited by 88
Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor‐2
Lai, L., Liu, J., Zhai, D., Lin, Q., He, L., Dong, Y., Zhang, J., Lu, B., Chen, Y., Yi, Z., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01532.x · Cited by 88
The Cardiovascular Physiology and Pharmacology of Endothelin-1
Thorin, É., & Clozel, M. (2010) · Advances in pharmacology · doi:10.1016/b978-0-12-385061-4.00001-5 · Cited by 87
Adenosine and Related Drugs in Brain Diseases: Present and Future in Clinical Trials
Lopes, L. V., Sebastião, A. M., & Ribeiro, J. A. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795347591 · Cited by 88
Anaplastic Lymphoma Kinase (ALK) Receptor Tyrosine Kinase: A Catalytic Receptor with Many Faces
Huang, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113448 · Cited by 89
A structural chemogenomics analysis of aminergic GPCRs : lessons for histamine receptor ligand design
Kooistra, A. J., Kuhne, S., de Esch, I. J. P., Leurs, R., & de Graaf, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12248 · Cited by 87
Treatment with hydrogen sulfide alleviates streptozotocin‐induced diabetic retinopathy in rats
Si, Y., Wang, J., Guan, J., Zhou, L., Sheng, Y., & Zhao, J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12163 · Cited by 87
Low dose of propranolol down‐modulates bone resorption by inhibiting inflammation and osteoclast differentiation
Rodrigues, W. F., Madeira, M. F. M., Silva, T. A., Clemente‐Napimoga, J. T., Miguel, C., da Silva, V. J. D., Neto, O. B., Lopes, A. H., & Napimoga, M. H. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01686.x · Cited by 89
Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II
Friso, A., Tomanin, R., Salvalaio, M., & Scarpa, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00565.x · Cited by 86
Biased agonism at serotonin 5-HT1Areceptors: preferential postsynaptic activity for improved therapy of CNS disorders
Newman‐Tancredi, A. (2011) · Neuropsychiatry · doi:10.2217/npy.11.12 · Cited by 86
Bias in chemokine receptor signalling
Zweemer, A. J. M., Toraskar, J., Heitman, L. H., & IJzerman, A. P. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.02.004 · Cited by 87
A common intracellular allosteric binding site for antagonists of the CXCR2 receptor
Salchow, K., Bond, M., Evans, S., Press, N., Charlton, S. J., Hunt, P., & Bradley, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00623.x · Cited by 85
Inhibition of angiotensin‐converting enzyme stimulates fracture healing and periosteal callus formation – role of a local renin‐angiotensin system
García, P., Schwenzer, S., Slotta, J., Scheuer, C., Tami, A., Holstein, J. H., Histing, T., Burkhardt, M., Pohlemann, T., & Menger, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00651.x · Cited by 85
Hydrogen sulfide‐induced mechanical hyperalgesia and allodynia require activation of both Cav3.2 and TRPA1 channels in mice
Okubo, K., Matsumura, M., Kawaishi, Y., Aoki, Y., Matsunami, M., Okawa, Y., Sekiguchi, F., & Kawabata, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01886.x · Cited by 85
Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats
Liu, W. J., Jin, H. Y., Lee, K. A., Xie, S. H., Baek, H. S., & Park, T. S. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01272.x · Cited by 84
Anti‐inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia are mediated via TGFβ1 regulation
Stienen, M. N., Haghikia, A., Dambach, H., Thöne, J., Wiemann, M., Gold, R., Chan, A., Dermietzel, R., Faustmann, P. M., Hinkerohe, D., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01038.x · Cited by 84
Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer‐induced pain
Curto-Reyes, V., Llames, S. G., Hidalgo, A., Menéndez, L., & Baamonde, A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00629.x · Cited by 84
Previously unsuspected widespread cellular and tissue distribution of β-adrenoceptors and its relevance to drug action
Daly, C. J., & McGrath, J. C. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.02.008 · Cited by 84
Lipoxin A4 attenuates zymosan‐induced arthritis by modulating endothelin‐1 and its effects
Conte, F. D. P., Menezes‐de‐Lima, O., Verri, W. A., Jr., Cunha, F. Q., Penido, C., & Henriques, M. D. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00950.x · Cited by 83
Distinct expression and ligand‐binding profiles of two constitutively active GPR17 splice variants
Benned‐Jensen, T., & ROSENKILDE, M. M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00633.x · Cited by 83
Physical and functional interaction between CB1cannabinoid receptors and β2‐adrenoceptors
Hudson, B. D., Hébert, T. E., & Kelly, M. E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00681.x · Cited by 83
TCN 201 selectively blocks GluN2A-containing NMDARs in a GluN1 co-agonist dependent but non-competitive manner
Edman, S. J., McKay, S., Macdonald, L. J., Samadi, M., Livesey, M. R., Hardingham, G. E., & Wyllie, D. J. A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.027 · Cited by 85
A study of subunit selectivity, mechanism and site of action of the delta selective compound 2 ( DS2 ) at human recombinant and rodent native GABAA receptors
Jensen, M., Wafford, K. A., Brown, A., Belelli, D., Lambert, J., & Mirza, N. R. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12001 · Cited by 85
Selective α7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis
Snoek, S. A., Verstege, M. I., van der Zanden, E. P., Deeks, N. J., Bulmer, D. C., Skynner, M. J., Lee, K. C., Velde, A. A. T., Boeckxstaens, G. E., & de Jonge, W. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00699.x · Cited by 83
MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models
Naguib, M., Diaz, P., Xu, J. J., Astruc‐Diaz, F., Craig, S., Vivas‐Mejia, P., & Brown, D. L. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.340 · Cited by 82
Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta‐cells, isolated pancreatic islets and mice
McKillop, A. M., Moran, B. M., Abdel‐Wahab, Y. H. A., & Flatt, P. R. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12356 · Cited by 84
Positive allosteric modulation of the human cannabinoid (CB 1 ) receptor by RTI‐371, a selective inhibitor of the dopamine transporter
Navarro, H. A., Howard, J. L., Pollard, G. T., & Carroll, F. I. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00124.x · Cited by 82
Regional‐ and agonist‐dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists
Broad, J., Mukherjee, S., Samadi, M., Martin, J., Dukes, G. E., & Sanger, G. J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02009.x · Cited by 82
Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations
Ludolph, A. G., Udvardi, P. T., Schaz, U., Henes, C., Adolph, O., Weigt, H. U., Fegert, J. M., Boeckers, T. M., & Föhr, K. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00707.x · Cited by 84
Shikonin inhibits maturation of bone marrow‐derived dendritic cells and suppresses allergic airway inflammation in a murine model of asthma
Lee, C., Wang, C., Lai, Y., Kang, J., Liao, J., Chiang, B., Chen, H., & Cheng, Y. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00972.x · Cited by 82
Release of ATP from rat urinary bladder mucosa: role of acid, vanilloids and stretch
Sadananda, P., Shang, F., Liu, L., Mansfield, K. J., & Burcher, E. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00431.x · Cited by 82
The μ‐opioid receptor agonist morphine, but not agonists at δ‐ or κ‐opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors
Da Fonseca Pacheco, D., Klein, A., De Castro Perez, A., Da Fonseca Pacheco, C. M., De Francischi, J. N., & Duarte, I. D. G. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.175 · Cited by 81
Estrogen Receptors and Estrogen-Induced Uterine Vasodilation in Pregnancy
Bai, J., Qi, Q.-R., Li, Y., Day, R., Makhoul, J., Magness, R. R., & Chen, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124349 · Cited by 82
AVE 0991, a non‐peptide mimic of angiotensin‐(1–7) effects, attenuates pulmonary remodelling in a model of chronic asthma
Rodrigues‐Machado, M. D. G., Magalhães, G. S., Cardoso, J. A., Kangussu, L. M., Murari, A., Caliari, M. V., Oliveira, M. L., Cara, D. C., Noviello, M. L. M., Marques, F. D., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12318 · Cited by 81
The Electro‐Mechanical window: a risk marker for Torsade de Pointes in a canine model of drug induced arrhythmias
van der Linde, H. J., Deuren, B. V., Somers, Y., Loenders, B., Towart, R., & Gallacher, D. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00934.x · Cited by 81
An overview on Estrogen receptors signaling and its ligands in breast cancer
Khan, M. Z. I., Uzair, M., Nazli, A., & Chen, J. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114658 · Cited by 82
The antinociceptive triterpene β‐amyrin inhibits 2‐arachidonoylglycerol (2‐AG) hydrolysis without directly targeting cannabinoid receptors
Chicca, A., Marazzi, J., & Gertsch, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02059.x · Cited by 82
Obovatol attenuates microglia‐mediated neuroinflammation by modulating redox regulation
Ock, J., Han, H. S., Hong, S. H., Lee, S. Y., Han, Y., Kwon, B., & Suk, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00659.x · Cited by 79
Vasorelaxation induced by prostaglandin E2in human pulmonary vein: role of the EP4receptor subtype
Foudi, N., Kotelevets, L., Louedec, L., Lesèche, G., Hénin, D., Chastre, E., & Norel, X. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.214 · Cited by 80
Extracellular Loop 2 of the Free Fatty Acid Receptor 2 Mediates Allosterism of a Phenylacetamide Ago-Allosteric Modulator
Smith, N. J., Ward, R. J., Stoddart, L. A., Hudson, B. D., Kostenis, E., Ulven, T., Morris, J. C., Tränkle, C., Tikhonova, I. G., Adams, D. R., et al. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.070789 · Cited by 79
Primary afferents with TRPM8 and TRPA1 profiles target distinct subpopulations of rat superficial dorsal horn neurones
Wrigley, P. J., Jeong, H., & Vaughan, C. W. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00167.x · Cited by 80
Cannabinoid CB2receptor attenuates morphine‐induced inflammatory responses in activated microglial cells
Merighi, S., Gessi, S., Varani, K., Fazzi, D., Mirandola, P., & Borea, P. A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01948.x · Cited by 79
The role of epoxyeicosatrienoic acids in the cardiovascular system
Yang, L. L. H., Maki-Petaja, K. M., Cheriyan, J., McEniery, C. M., & Wilkinson, I. B. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12603 · Cited by 79
Analgesic conotoxins: block and G protein‐coupled receptor modulation of N‐type (CaV2.2) calcium channels
Adams, D. J., Callaghan, B. P., & Berecki, G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01781.x · Cited by 81
Mechanisms That Determine the Internal Environment of the Developing Brain: A Transcriptomic, Functional and Ultrastructural Approach
Liddelow, S. A., Dzięgielewska, K. M., Ek, C. J., Habgood, M. D., Bauer, H., Bauer, H., Lindsay, H. A., Wakefield, M. J., Strazielle, N., Kratzer, I., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065629 · Cited by 78
Agonists with supraphysiological efficacy at the muscarinic M 2ACh receptor
Schrage, R., Seemann, W. K., Klöckner, J., Dallanoce, C., Racké, K., Kostenis, E., Amici, M. D., Holzgrabe, U., & Mohr, K. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12003 · Cited by 78
β−Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR‐α, PPAR‐γ and TRPV1, but not CB1 or CB2 receptors
Benito, C., Tolón, R. M., Castillo, A. I., Ruiz‐Valdepeñas, L., Martínez-Orgado, J. A., Fernández, J., Vázquez, C., Cravatt, B. F., & Romero, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01889.x · Cited by 81
Submaximal PPARγ activation and endothelial dysfunction: new perspectives for the management of cardiovascular disorders
Balakumar, P., & Kathuria, S. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01938.x · Cited by 78
Novel Δ9‐tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects
Klumpers, L. E., Beumer, T. L., van Hasselt, J. G. C., Lipplaa, A., Karger, L. B., Kleinloog, D., Freijer, J. I., de Kam, M. L., & van Gerven, J. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04164.x · Cited by 78
Anti‐nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1adenosine receptors
Schmidt, A., Böhmer, A. E., Antunes, C., Schallenberger, C., Porciúncula, L., Elisabetsky, E., Lara, D., & Souza, D. O. (2008) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00025.x · Cited by 78
A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes
Stefanich, E., Danilenko, D. M., Wang, H., O’Byrne, S., Erickson, R., Gelzleichter, T. R., Hiraragi, H., Chiu, H., Ivelja, S., Jeet, S., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01205.x · Cited by 78
Increased brain damage after ischaemic stroke in mice lacking the chemokine receptor CCR5
Sorce, S., Bonnefont, J., Julien, S., Marq‐Lin, N., Rodríguez, I., Dubois‐Dauphin, M., & Krause, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00697.x · Cited by 79
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis
Rossi, S., Giudice, T. L., Chiara, V. D., Musella, A., Studer, V., Motta, C., Bernardi, G., Martino, G., Furlan, R., Martorana, A., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01579.x · Cited by 77
Many ways to dilate the P2X7 receptor pore
Pelegrı́n, P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01325.x · Cited by 77
The monoacylglycerol lipase inhibitor JZL 184 attenuates LPS ‐induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action
Kerr, D., Harhen, B., Okine, B. N., Egan, L. J., Finn, D. P., & Roche, M. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02237.x · Cited by 77
5‐ HT3 receptor antagonists ameliorate 5‐fluorouracil‐induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells
Yasuda, M., Kato, S., Yamanaka, N., Iimori, M., Matsumoto, K., Utsumi, D., Kitahara, Y., Amagase, K., Horie, S., & Takeuchi, K. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12019 · Cited by 77
The K+ channels KCa3.1 and Kv1.3 as novel targets for asthma therapy
Bradding, P. H., & Wulff, H. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00362.x · Cited by 77
Peripheral selectivity of the novel cannabinoid receptor antagonist TM 38837 in healthy subjects
Klumpers, L. E., Fridberg, M., de Kam, M. L., Little, P. B., Jensen, N. O., Kleinloog, H. D., Elling, C., & van Gerven, J. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12141 · Cited by 77
Upregulation of K2P5.1 potassium channels in multiple sclerosis
Bittner, S., Bobak, N., Herrmann, A. M., Göbel, K., Meuth, P., Höhn, K., Stenner, M., Budde, T., Wiendl, H., & Meuth, S. G. (2010) · Annals of Neurology · doi:10.1002/ana.22010 · Cited by 76
Inhibiting the TLR4‐MyD88 signalling cascade by genetic or pharmacological strategies reduces acute alcohol‐induced sedation and motor impairment in mice
Wu, Y. H., Lousberg, E. L., Moldenhauer, L. M., Hayball, J. D., Coller, J. K., Rice, K. C., Watkins, L. R., Somogyi, A. A., & Hutchinson, M. R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01572.x · Cited by 76
Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT2) receptor
Wunder, F., Tinel, H., Kast, R., Geerts, A., Becker, E., Kolkhof, P., Hütter, J. F., Ergüden, J., & Härter, M. W. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00730.x · Cited by 76
Anatomical Transcriptome of G Protein-Coupled Receptors Leads to the Identification of a Novel Therapeutic Candidate GPR52 for Psychiatric Disorders
Komatsu, H., Maruyama, M., Shuuhei, Y., Shinohara, T., Sakuma, K., Imaichi, S., Chikatsu, T., Kuniyeda, K., Siu, F. K., Peng, L. S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090134 · Cited by 84
Estrogens and Coronary Artery Disease
Meyer, M. R., & Barton, M. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.05.003 · Cited by 79
The Rho kinase inhibitor Fasudil up‐regulates astrocytic glutamate transport subsequent to actin remodelling in murine cultured astrocytes
Lau, C., O'Shea, R., Broberg, B. V., Bischof, L., & Beart, P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01259.x · Cited by 75
P2X3-Containing Receptors as Targets for the Treatment of Chronic Pain
Krajewski, J. L. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00934-2 · Cited by 75

Authors: Alexander, S., Mathie, A., & Peters, J.
Affiliations: University of Nottingham (GB)
Medway School of Pharmacy (GB)
University of Dundee (GB)
ORCID: Mathie, A
Venue: British Journal of Pharmacology
Publisher: Wiley
Published: 2011-11
Volume: 164
Issue: s1
Pages: S1-324
ISSN: 0007-1188 (ISSN-L)
1476-5381
DOI: 10.1111/j.1476-5381.2011.01649_1.x
PMC: PMC3315626
OpenAlex: W2069380892
Cited by: 1,947
References: 2
Citations by year: 2026: 4 · 2025: 13 · 2024: 12 · 2023: 14 · 2022: 23 · 2021: 19 · 2020: 20 · 2019: 35 · 2018: 27 · 2017: 36 · 2016: 47 · 2015: 59 · 2014: 71 · 2013: 191 · 2012: 279
FWCI: 109.61
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: British Journal of Pharmacology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Discovery Research Portal (University of Dundee) (submittedVersion)
Kent Academic Repository (University of Kent) (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: therapeutic target, G protein-coupled receptors, ligand-gated ion channels, ion channels, nuclear receptors, transporters, enzymes, receptor nomenclature, pharmacological tools
MeSH terms: Animals, Humans, Ion Channels, Receptors, Cell Surface, Receptors, Cytoplasmic and Nuclear

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Guide to Receptors and Channels (GRAC), 5th edition

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks